Related Experiment Video
Updated: May 15, 2026
11:31
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
Published on: August 16, 2019
Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus
A E Barcala Tabarrozzi1, C N Castro, R A Dewey
1Instituto de Investigación en Biomedicina de Buenos Aires (IBioBA), CONICET, Instituto Partner de la Sociedad Max Planck, Buenos Aires.
Clinical and Experimental Immunology
|January 5, 2013
Summary
Type 1 diabetes (T1DM) involves autoimmune destruction of insulin-producing beta cells. Cell-based therapies show promise for halting this autoimmune response and preserving beta cell function.
Area of Science:
- Immunology
- Endocrinology
- Cell Biology
Background:
- Type 1 diabetes mellitus (T1DM) is an autoimmune disease causing beta cell destruction and impaired glucose homeostasis.
- Genetic predisposition and environmental factors initiate T1DM, necessitating novel therapeutic strategies.
- Despite research, a definitive cure for T1DM remains elusive, highlighting the need for advanced treatments.
Purpose of the Study:
- To explore the role of immune cells in T1DM pathogenesis.
- To evaluate the therapeutic potential of targeting immune cells in T1DM treatment.
- To discuss emerging cell-based therapies for T1DM management.
Main Methods:
- Review of current literature on T1DM pathogenesis and immune cell involvement.
- Analysis of therapeutic strategies targeting immune cells in T1DM.
- Discussion of ongoing and future clinical trials involving cell-based interventions.
Main Results:
- Various immune cells contribute significantly to T1DM development.
- Cell-based therapies, including stem cells, dendritic cells, and regulatory T cells, demonstrate therapeutic potential.
- Ex vivo manipulation and combination approaches are being explored for enhanced efficacy.
Conclusions:
- Targeting immune cells offers a promising avenue for T1DM treatment.
- Cell-based therapies may halt autoimmune destruction and preserve beta cell mass.
- Future clinical trials are expected to advance cell-based interventions for T1DM management.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...